This study aimed to investigate the gut microbiota–immune system–nerve axis in CIDP by integrating three complementary layers: genetic variation in the IL18 promoter, systemic inflammatory cytokines (IL-2, TNF-α, IL-18), and SCFAs quantified in stool, serum and CSF. This evidence concerns the gene IL2 and chronic inflammatory demyelinating polyradiculoneuropathy.